NewAmsterdam Pharma Co N.V. Assets in USD from Q4 2022 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: NewAmsterdam Pharma Co N.V. quarterly Assets history and growth rate from Q4 2022 to Q3 2025.
NewAmsterdam Pharma Co N.V. Assets for the quarter ending September 30, 2025 was $786M, a 79.1% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

NewAmsterdam Pharma Co N.V. Quarterly Assets (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$786M	+$347M	+79.1%	Sep 30, 2025	10-Q	2025-11-05
Q2 2025	$815M	+$368M	+82.5%	Jun 30, 2025	10-Q	2025-08-06
Q1 2025	$818M	+$330M	+67.5%	Mar 31, 2025	10-Q	2025-05-08
Q4 2024	$865M	+$518M	+149%	Dec 31, 2024	10-Q	2025-11-05
Q3 2024	$439M			Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$447M			Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$488M			Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$347M	-$131M	-27.5%	Dec 31, 2023	10-K	2025-02-26
Q4 2022	$478M			Dec 31, 2022	10-K	2024-02-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.